RxDoctor Payments Data

Richard Clark

Physician Assistant · Albany, NYNPI 1033421243

Payments from drug & device makers

$14,914in general payments, 2019–2025

Across 867 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • GSK$1K
  • Lilly USA, LLC$962
  • Pfizer$911
  • AstraZeneca$870
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,889100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie136$1,867
Novo Nordisk92$1,629
GSK92$1,478
Lilly USA, LLC57$962
Pfizer61$911
AstraZeneca26$870
Johnson & Johnson47$694
Boehringer Ingelheim28$532
Exact Sciences21$487
Amgen26$406
Bayer20$341
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$320
Astellas Pharma US Inc16$269
Merck19$256
Sanofi-aventis U.S. LLC9$211
Kowa Pharmaceuticals America, Inc.11$194
Phathom Pharmaceuticals, Inc.14$192
Electromed, Inc.3$183
Novartis10$182
Sumitomo Pharma America, Inc.9$165
Abbott8$153
E.r. Squibb & Sons, L.L.C.9$149
Amarin Pharma, Inc.7$132
Biohaven Pharmaceutical Holding Company Ltd.8$129
Paratek Pharmaceuticals, Inc.7$127
Biohaven Pharmaceuticals, Inc.12$127
IBSA Pharma Inc.7$127
Viiv Healthcare Company6$126
Currax Pharmaceuticals LLC8$120
Dexcom, Inc.5$103
Antares Pharma, Inc.5$102
Esperion Therapeutics, Inc.4$99
Vanda Pharmaceuticals Inc.5$99
Axsome Therapeutics, Inc.4$81
Takeda Pharmaceuticals U.S.A., Inc.5$81
Arbor Pharmaceuticals, Inc.5$78
Mannkind Corporation4$74
Optinose US, Inc.4$73
Sunovion Pharmaceuticals Inc.4$62
Idorsia Pharmaceuticals US Inc3$60
Sanofi Pasteur Inc.3$55
Lundbeck LLC3$54
Teva Pharmaceuticals USA, Inc.3$50
ARS Pharmaceuticals Operations, Inc.2$48
Eisai Inc.2$47
Jazz Pharmaceuticals Inc.2$46
Boston Scientific2$44
Tolmar, Inc.2$43
UCB, Inc.1$35
Halozyme Inc2$34
Renalytix AI, Inc.2$30
Gilead2$29
Amneal Pharmaceuticals LLC1$27
Seqirus USA Inc1$22
Avanir Pharmaceuticals, Inc.1$21
Aimmune Therapeutics, Inc.1$18
Clarus Therapeutics Inc.1$16
Kaleo, Inc.1$16
La Jolla Pharmaceutical Company1$16
Almatica Pharma LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,914 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$73,935
Medicare patients
413
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin85$114,715
OzempicSemaglutide65$109,728
EliquisApixaban83$106,715
JanuviaSitagliptin Phosphate92$103,865
FarxigaDapagliflozin Propanediol47$56,990
TradjentaLinagliptin33$36,264
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$29,144
JanumetSitagliptin Phos/Metformin Hcl15$25,071
XareltoRivaroxaban26$22,396
MyrbetriqMirabegron16$19,879
Nurtec OdtRimegepant Sulfate12$13,601
OxycontinOxycodone Hcl11$8,655
SynthroidLevothyroxine Sodium79$6,918
Fluticasone-SalmeterolFluticasone Propion/Salmeterol66$6,677
Breo ElliptaFluticasone/Vilanterol17$6,593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$532$150,978118 claims
MerckJanuvia, Janumet$256$128,936107 claims
PfizerEliquis, Nurtec Odt$911$120,31695 claims
Novo NordiskOzempic$1,629$109,72865 claims
AstraZenecaFarxiga$870$56,99047 claims
GSKTrelegy Ellipta, Breo Ellipta$1,478$35,73763 claims
Johnson & JohnsonXarelto$694$22,39626 claims
Astellas Pharma US IncMyrbetriq$269$19,87916 claims
AbbVieSynthroid$1,867$6,91879 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$27$5,866311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →